AstronauTx

Private

LondonHealthcare & Life Scienceshttps://astronautx.bio/

Last Round

Series A

Oct 9, 2023

Total Funding Raised

$70.17M

Company Overview

AstronauTx is a biotechnology company that develops small-molecule therapeutics to treat Alzheimer's disease and other neurodegenerative disorders by correcting disrupted brain physiology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule therapeuticsneurodegenerative diseaseAlzheimer's researchastrocyte dysfunctiondrug discoverybiotech startuppreclinical developmenttherapeutic pipelinedrug licensingbrain homeostasisneuroscience biotechtranslational biologyCNS drug discoverypharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AstronauTx Comparables

Compare AstronauTx with similar companies based on industry and business-model similarity.

AstronauTx comparables — related companies by embedding similarity
Company	Similarity	Market Cap
GliaPharm SA	86%
Muna Therapeutics	83%
Cellestial Health	81%

View all Comparables

AstronauTx Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 9, 2023
Grant	Sep 1, 2023
Seed	Mar 24, 2020
Seed	Aug 12, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Hannah Pearce

Chief Operating Officer

Executive Team

AstronauTx Investors

Notable investors and investment history

AstronauTx investors
Investor	Rounds
Innovate UK	Grant
MPM Capital	Series A
EQT Life Sciences	Series A
UKRI Innovate UK	Grant
MPM BioImpact	Series A
Albion Capital	Seed
Brandon Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 7, 2026
Adam Rosenberg appointed as Chair of the Board of Directors.
Oct 9, 2023
$61M round led by Novartis

View all signals

AstronauTx Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AstronauTx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AstronauTx's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range23

Year Founded2019

Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.